GP Kidd/Getty Images
- A top M&A banker said Big Pharma will be on the hunt for more acquisitions in 2025.
- Major drugs including Keytruda and Eliquis will see patent exclusivity expire in coming years.
- Pharma companies look at areas such as obesity to supplement







